Share on LinkedInShare on LinkedIn

ARTICLE · 17 AUGUST 2017

Canada's Patented Medicines Regime: Trending Upward And Onward

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 2016/2017 for the Patented Medicines (Notice of Compliance) Regulations and Data Protection.

CanadaIntellectual Property

On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 2016/2017 for the Patented Medicines (Notice of Compliance) Regulations and Data Protection. The report compares annual statistics on Health Canada's administration of the PMNOC Regulations and Data Protection Regulations.  Annual statistics are compiled for the federal government's fiscal year, which runs from April 1 to March 31.

With significant changes to Canada's patented medicines regime on the horizon (see our previously reported articles on these changes here and here), the Report highlights an increase in the use of the patented medicines regime by innovator companies, and, at the same time, a decrease in the number of generic submissions challenging the patents listed on the Patent Register and medicines subject to data protection.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from